These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25550803)

  • 1. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.
    Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L
    Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
    Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
    Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
    Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
    Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
    Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G
    Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC; Hu DD; Zhao L; Li N; Shen HY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y; Qin H; Cui Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
    Qiu Z; Li H; Wang J; Sun C
    Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
    Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M
    Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells.
    Luo L; Xia L; Zha B; Zuo C; Deng D; Chen M; Hu L; He Y; Dai F; Wu J; Wang C; Wang Y; Zhang Q
    Biomed Pharmacother; 2018 Oct; 106():983-990. PubMed ID: 30119270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.
    Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).
    Jazdzewski K; Boguslawska J; Jendrzejewski J; Liyanarachchi S; Pachucki J; Wardyn KA; Nauman A; de la Chapelle A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E546-53. PubMed ID: 21159845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA deregulation in human thyroid papillary carcinomas.
    Pallante P; Visone R; Ferracin M; Ferraro A; Berlingieri MT; Troncone G; Chiappetta G; Liu CG; Santoro M; Negrini M; Croce CM; Fusco A
    Endocr Relat Cancer; 2006 Jun; 13(2):497-508. PubMed ID: 16728577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1.
    Cao XZ; Bin H; Zang ZN
    Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2.
    Hua K; Jin J; Zhang H; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 Oct; 49(4):1531-1540. PubMed ID: 27633373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
    Wang Z; Zhang H; Zhang P; Dong W; He L
    Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.